Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2013 | 1 |
2014 | 1 |
2016 | 1 |
2017 | 1 |
2020 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Comparison of three commercial decision support platforms for matching of next-generation sequencing results with therapies in patients with cancer.
ESMO Open. 2020 Sep;5(5):e000872. doi: 10.1136/esmoopen-2020-000872.
ESMO Open. 2020.
PMID: 32967919
Free PMC article.
Experience with lenalidomide in an Austrian non-study population with advanced myelofibrosis.
Burgstaller S, Fridrik M, Hojas S, Kühr T, Ludwig H, Mayrbäurl B, Pöhnl R, Pötscher M, Schlögl E, Zauner D, Thaler J, Gisslinger H.
Burgstaller S, et al. Among authors: hojas s.
Wien Klin Wochenschr. 2013 Apr;125(7-8):196-9. doi: 10.1007/s00508-013-0345-z. Epub 2013 Mar 28.
Wien Klin Wochenschr. 2013.
PMID: 23536018
Item in Clipboard
Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications.
Pleyer L, Burgstaller S, Stauder R, Girschikofsky M, Sill H, Schlick K, Thaler J, Halter B, Machherndl-Spandl S, Zebisch A, Pichler A, Pfeilstöcker M, Autzinger EM, Lang A, Geissler K, Voskova D, Geissler D, Sperr WR, Hojas S, Rogulj IM, Andel J, Greil R.
Pleyer L, et al. Among authors: hojas s.
J Hematol Oncol. 2016 Apr 16;9:39. doi: 10.1186/s13045-016-0263-4.
J Hematol Oncol. 2016.
PMID: 27084507
Free PMC article.
Item in Clipboard
Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group.
Pleyer L, Döhner H, Dombret H, Seymour JF, Schuh AC, Beach CL, Swern AS, Burgstaller S, Stauder R, Girschikofsky M, Sill H, Schlick K, Thaler J, Halter B, Machherndl Spandl S, Zebisch A, Pichler A, Pfeilstöcker M, Autzinger EM, Lang A, Geissler K, Voskova D, Sperr WR, Hojas S, Rogulj IM, Andel J, Greil R.
Pleyer L, et al. Among authors: hojas s.
Int J Mol Sci. 2017 Feb 15;18(2):415. doi: 10.3390/ijms18020415.
Int J Mol Sci. 2017.
PMID: 28212292
Free PMC article.
Item in Clipboard
Megakaryocytic morphology and clinical parameters in essential thrombocythemia, polycythemia vera, and primary myelofibrosis with and without JAK2 V617F.
Vytrva N, Stacher E, Regitnig P, Zinke-Cerwenka W, Hojas S, Hubmann E, Porwit A, Bjorkholm M, Hoefler G, Beham-Schmid C.
Vytrva N, et al. Among authors: hojas s.
Arch Pathol Lab Med. 2014 Sep;138(9):1203-9. doi: 10.5858/arpa.2013-0018-OA.
Arch Pathol Lab Med. 2014.
PMID: 25171702
Free article.
Item in Clipboard
Cite
Cite